Biliary atresia is a rare disease but remains the most common indication for pediatric liver transplantation as there are no effective medical therapies to slow progression after diagnosis. Variable contribution of genetic, immune, and environmental factors contributes to disease heterogeneity among patients with biliary atresia. Developing a deeper understanding of the disease mechanism will help to develop targeted medical therapies and improve patient outcomes.
Keywords: Biliary atresia; Neonatal cholestasis; Pediatric liver transplantation; Transplant outcomes.
Copyright © 2022 Elsevier Inc. All rights reserved.